187 related articles for article (PubMed ID: 19620402)
1. Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1.
Skokowa J; Fobiwe JP; Dan L; Thakur BK; Welte K
Blood; 2009 Oct; 114(14):3044-51. PubMed ID: 19620402
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of myeloid-specific transcription factors in congenital neutropenia.
Skokowa J; Welte K
Ann N Y Acad Sci; 2009 Sep; 1176():94-100. PubMed ID: 19796237
[TBL] [Abstract][Full Text] [Related]
3. LEF-1 is a decisive transcription factor in neutrophil granulopoiesis.
Skokowa J; Welte K
Ann N Y Acad Sci; 2007 Jun; 1106():143-51. PubMed ID: 17360796
[TBL] [Abstract][Full Text] [Related]
4. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells.
Gupta K; Kuznetsova I; Klimenkova O; Klimiankou M; Meyer J; Moore MA; Zeidler C; Welte K; Skokowa J
Blood; 2014 Apr; 123(16):2550-61. PubMed ID: 24394665
[TBL] [Abstract][Full Text] [Related]
6. Defective G-CSFR signaling pathways in congenital neutropenia.
Skokowa J; Welte K
Hematol Oncol Clin North Am; 2013 Feb; 27(1):75-88, viii. PubMed ID: 23351989
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
Zeidler C; Germeshausen M; Klein C; Welte K
Br J Haematol; 2009 Feb; 144(4):459-67. PubMed ID: 19120359
[TBL] [Abstract][Full Text] [Related]
8. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia.
Skokowa J; Cario G; Uenalan M; Schambach A; Germeshausen M; Battmer K; Zeidler C; Lehmann U; Eder M; Baum C; Grosschedl R; Stanulla M; Scherr M; Welte K
Nat Med; 2006 Oct; 12(10):1191-7. PubMed ID: 17063141
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.
Li FQ; Person RE; Takemaru K; Williams K; Meade-White K; Ozsahin AH; Güngör T; Moon RT; Horwitz M
J Biol Chem; 2004 Jan; 279(4):2873-84. PubMed ID: 14594802
[TBL] [Abstract][Full Text] [Related]
10. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.
Grenda DS; Johnson SE; Mayer JR; McLemore ML; Benson KF; Horwitz M; Link DC
Blood; 2002 Nov; 100(9):3221-8. PubMed ID: 12384420
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.
Grenda DS; Murakami M; Ghatak J; Xia J; Boxer LA; Dale D; Dinauer MC; Link DC
Blood; 2007 Dec; 110(13):4179-87. PubMed ID: 17761833
[TBL] [Abstract][Full Text] [Related]
12. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.
Skokowa J; Klimiankou M; Klimenkova O; Lan D; Gupta K; Hussein K; Carrizosa E; Kusnetsova I; Li Z; Sustmann C; Ganser A; Zeidler C; Kreipe HH; Burkhardt J; Grosschedl R; Welte K
Nat Med; 2012 Oct; 18(10):1550-9. PubMed ID: 23001182
[TBL] [Abstract][Full Text] [Related]
13. Severe congenital neutropenia and the unfolded protein response.
Xia J; Link DC
Curr Opin Hematol; 2008 Jan; 15(1):1-7. PubMed ID: 18043239
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease.
Ancliff PJ; Gale RE; Liesner R; Hann IM; Linch DC
Blood; 2001 Nov; 98(9):2645-50. PubMed ID: 11675333
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia.
Sera Y; Kawaguchi H; Nakamura K; Sato T; Habara M; Okada S; Ishikawa N; Kojima S; Katoh O; Kobayashi M
Haematologica; 2005 Aug; 90(8):1032-41. PubMed ID: 16079102
[TBL] [Abstract][Full Text] [Related]
16. Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring
Zeidler A; Borbaran-Bravo N; Dannenmann B; Ritter M; Nasri M; Klimiankou M; Kandabarau S; Zahabi A; König J; Zeidler C; Skokowa J; Welte K
Haematologica; 2024 May; 109(5):1393-1402. PubMed ID: 37855057
[TBL] [Abstract][Full Text] [Related]
17. Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia.
Zhuang D; Qiu Y; Kogan SC; Dong F
J Biol Chem; 2006 Apr; 281(16):10745-51. PubMed ID: 16500901
[TBL] [Abstract][Full Text] [Related]
18. Severe congenital neutropenia: inheritance and pathophysiology.
Skokowa J; Germeshausen M; Zeidler C; Welte K
Curr Opin Hematol; 2007 Jan; 14(1):22-8. PubMed ID: 17133096
[TBL] [Abstract][Full Text] [Related]
19. [Granulopoeisis and leukemogenesis: lessons from congenital neutropenia].
Donadieu J; Beaupain B; Bellanné-Chantelot C
Med Sci (Paris); 2008 Mar; 24(3):284-9. PubMed ID: 18334177
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.
Bellanné-Chantelot C; Clauin S; Leblanc T; Cassinat B; Rodrigues-Lima F; Beaufils S; Vaury C; Barkaoui M; Fenneteau O; Maier-Redelsperger M; Chomienne C; Donadieu J
Blood; 2004 Jun; 103(11):4119-25. PubMed ID: 14962902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
